Please login to the form below

Not currently logged in
Email:
Password:

PureTech Health appoints chief scientific officer

Dr Joseph Bolen brings 30 years of clinical experience to the biotech

PureTech Health Dr Joseph BolenBoston, US-based PureTech Health has appointed Dr Joseph Bolen as its chief scientific officer.

Dr Bolen will be responsible for the scientific development and advancement of PureTech Health's pipeline, working with the company's scientific advisory board and R&D team.

Bringing over 30 years of clinical development experience to the role, he joins from Moderna Therapeutics where he most recently served as president and chief scientific officer.

Prior to this, Dr Bolen was chief scientific officer and global head of oncology research at Millennium, Takeda's oncology business, and has held senior R&D positions at Bristol-Myers Squibb, Hoechst Marion Roussel and Schering-Plough.

Daphne Zohar, chief executive officer of PureTech Health, said: “We are tremendously excited to bring Joe's visionary leadership and drug development expertise to PureTech.

“Joe is a seasoned industry expert who brings the ideal balance of rigor and creativity to the role of chief scientific officer, and shares our vision for identifying and nurturing innovation that can potentially redefine healthcare.”

4th November 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics